Table 1.
MicroRNA aberrant expression in cancer.
| Tumor type | Upregulated miRNA | Downregulated miRNA | References |
|---|---|---|---|
| Glioblastoma | miR-21 | miR-7 | [121–125] |
| miR-221 | |||
| miR-222 | |||
| Lung | let7-5a | miR-1, let-7 family, miR-7, | [121, 126–130] |
| miR-17-92 cluster, miR-18b, | miR-15a/miR-16, miR-29 | ||
| miR-20a, miR-21, miR-34c, | family, miR-32, miR-137, | ||
| miR-106a, miR-155, miR-182, | miR-342 | ||
| miR-328 | miR-145 | ||
| Breast | miR-10b, miR-21, miR-22, | let-7, miR-7, miR-9-1, | [34, 131–133] |
| miR-27a, miR-155, miR-210, | miR-17/miR-20, miR-31, | ||
| miR-221, miR-222, miR-328, | miR-125a, miR-125b, | ||
| miR-373, miR-520c | miR-146, miR-200 family, | ||
| miR-205, miR-206, | |||
| miR-335 | |||
| Hepatocellular carcinoma | miR-17-92 cluster, miR-21, | miR-1, miR-34a | [134–140] |
| miR-143, miR-221 | miR-101, miR-122a | ||
| miR-224 | miR-125b | ||
| Gastric cancer | miR-21, miR-27a, miR-130b | miR-101, miR-143, miR-145 | [141–143] |
| Colorectal cancer | miR-17-92 cluster, miR-21 | miR-34a, miR-34b/c, miR-127, miR-143, | [144–149] |
| miR-145, miR-342 | |||
| Prostate cancer | miR-221, miR-222 | miR-15a-miR-16-1 cluster, | [144, 150–153] |
| miR-101, miR-127, | |||
| miR-449a | |||
| Lymphoma | miR-17-92 cluster, miR-155 | miR-143, miR-145 | [154–156] |
| CLL | miR-21, miR-155 | miR-15, miR-16, miR-29b, | [35, 156–160] |
| miR-29c, miR-34a, | |||
| miR-143, miR-145,miR-181b, miR-223 |
CLL: chronic lymphocytic lymphoma.